Evidence is graded on this page in four words: strong, moderate, emerging and limited. Standard medication for benign enlargement: strong (the MTOPS trial above). Heat for benign enlargement: moderate for transurethral microwave thermotherapy, the urological procedure that heats the gland from inside the urethra to high temperatures; a Cochrane review of 15 trials in 1,585 men found symptom scores fell by about two thirds with microwave thermotherapy and by about three quarters with transurethral resection, with resection giving the larger gain in flow (Hoffman et al., Cochrane Database Syst Rev, 2012). These results describe urological procedures and are not evidence for the supportive measures offered here.
Chronic prostatitis / chronic pelvic pain syndrome: the evidence for any single treatment is limited, and the physicians combine measures and measure the symptom score rather than promise a result. What the evidence does not show is that hormonal measures shrink a benign prostate in a controlled trial, and the hospital does not claim that they do.